CYTK FY 2022 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$95M+34.3% YoY

Gross Profit

-$146M-154.6% margin

Operating Income

-$324M-342.8% margin

Net Income

-$389M-411.2% margin

EPS (Diluted)

$-4.33

Cash Flow

Operating Cash Flow

-$300M

Free Cash Flow

-$311M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$1.1B

Stockholders' Equity

-$108M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$95M	$70M	+34.3%
Gross Profit	-$146M	-$90M	-63.4%
Operating Income	-$324M	-$186M	-74.0%
Net Income	-$389M	-$215M	-80.6%